Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: ziploc_1, zmanindc, rafunrafun, marzan, iryokabu, Number sleven
Search This Board: 
Last Post: 7/25/2021 12:43:06 PM - Followers: 1043 - Board type: Free - Posts Today: 16

AMARIN TICKER RELATED LINKS
Amarin Webpage
NASDAQ AMRN Quote 
Y! Finance AMRN Landing Page 
Seeking Alpha AMRN Landing Page
FinViz AMRN Landing Page


VASCEPA RELATED LINKS & Outside Organizational News
The EPA Drug Initiative (EPADI)
Vascepa Savings Card Program
FDA Orange Book entry for Vascepa
Vascepa Prescribing Information
Vascepa Marine DTC Patient Brochure
Nissui EPA Synthesis History & Methodology
FDA Approval of Vascepa for the Reduction of Triglyceride Levels ≥ 500mg/dL (26 Jul 2012)
Pure EPA Vascepa Now Available in Half-Gram Capsule Size (25 Oct 2016)
ADA’s 2019 Standards of Medical Care in Diabetes Incorporate Findings from REDUCE-IT (28 Mar 2019)
New 2019 Updates to the European Society of Cardiology and European Atherosclerosis Society’s Guidelines incorporate Reduce-IT (3 Sep 2019)
National Lipid Association’s New Position Statement on Use of Icosapent Ethyl (16 Sep 2019)
Independent Drug-Pricing Assessment Finds Vascepa Cost-Effective (17 Oct 2019)

RELEVANT SOCIAL MEDIA ACCOUNTS
Amarin Instagram - @amarincorp Amarin Twitter - @amarincorp Amarin LinkedIn Amarin ADP Portal - Job Openings Dr. Bhatt Twitter - @DLBHATTMD
TerraPharma Twitter - @TerraPharma1 John Cappello Twitter - @JohnCappello RafunRafun Twitter - @ra_fun K Trivedi Twitter - @GPUWorld  
 

VASCEPA CLINICAL TRIALS + FDA Meetings
Marine & Anchor (Amarin Led)
MARINE Study meets primary endpoints(29 Nov 2010)
ANCHOR Trial meets all Primary and Secondary Endpoints (18 Apr 2011)
Additional Inflammatory Marker Data from Marine and Anchor (22 Jan 2013)
New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in Marine and Anchor (8 April 2013)
FDA AD-Com Outcome for Anchor sNDA (16 October 2013)
FDA delays ANCHOR sNDA (20 Dec 2013)
Presentation of MARINE and ANCHOR analyses at AHA showing significant reduction of remnant-like particle cholesterol (17 Nov 2014)
Marine & Anchor Key Summaries (2017)
Vascepa showed reductions in potentially atherogenic lipids and inflammatory markers – Anchor post-hoc (12 Mar 2018)

REDUCE-IT (Amarin Led)
NIH Clinical Trial Page
Amarin Announces Dosing of First Patient in REDUCE-IT (7 Dec 2011)
Amarin and FDA Reaffirm Concurrence on REDUCE-IT through SPA Agreement Amendment (4 Aug 2016)
Amarin Randomizes Final Patient into REDUCE-IT (31 Aug 2016)
REDUCE-IT to Continue As Planned at Recommendation of Independent Data Monitoring Committee (14 Aug 2017)
REDUCE-IT Meets Primary Endpoint (24 Sep 2018)
REDUCE-IT Displayed 25% RRR in 5-Point MACE (10 Nov 2018)
REDUCE-IT NEJM Article(3 Jan 2019)
REDUCE-IT showed 30% reduction in total Cardiovascular events (18 Mar 2019)
Amarin submits sNDA seeking new indication based on REDUCE-IT (28 Mar 2019)
FDA Grants Priority Review for Vascepa sNDA (29 May 2019)
Amarin Notified of Ad-Com Meeting Planned for Nov 2019 (8 Aug 2019)
REDUCE-IT USA-specific Results released (11 Nov 2019)
FDA AD-Com Outcome for REDUCE-IT sNDA (14 Nov 2019)
REDUCE-IT related data presented at 2019 AHA (18 Nov 2019)

Law Suits
Amarin Granted Summary Judgement against FDA seeking NCE market exclusivity (28 May 2015)
First Amendment Decision a win for Amarin & Physician Plaintiffs (7 Aug 2015)
Court Approves Proposed Settlement Terms in Amarin First Amendment Litigation (9 Mar 2016)
Amarin announces patent litigation settlement agreement with TEVA (24 May 2018)
Section Pending

PARTNERSHIPS / OVERSEAS
Amarin and Eddingpharm announce agreement for Vascepa in China (26 Feb 2015)
Amarin and HLS announce agreement for Vascepa in Canada (25 Sep 2017)
Commencement of Vascepa Clinical Development in China (17 Jan 2018)
Biologix and Amarin announce approval of Vascepa in Lebanon for patients with Triglyceride Levels ≥ 500mg/dL (21 Mar 2018)
Amarin & Mochida Announce Collaboration on Future Development of EPA-Based Drug Products and Indications (12 Jun 2018)
Biologix and Amarin announce approval of Vascepa in UAE for patients with Triglyceride Levels ≥ 500mg/dL (26 Jul 2018)
Vascepa granted Priority Review from Health Canada New Drug Submission, anticipated to be filed in April 2019 by HLS (29 Mar 2019)
HLS files New Drug Submission for Vascepa with Health Canada (29 April 2019)

PATENTS
Amarin list of Patents on Justia (h/t @Terrapharma1)

EPA Trials for other indications
Section Pending

Non-Vascepa (AMR-101) Amarin Trials
Section Pending

 

AMRN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN News: Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on August 5, 2021 07/15/2021 06:35:00 AM
AMRN News: CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Tomorrow.  Register Now 07/06/2021 07:00:00 AM
AMRN News: Sino United (OTC Pink: SUIC) $200 Million Commitment, Signs with Suntech, the Largest Taiwan O2O Company. 06/30/2021 07:30:00 AM
AMRN News: CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference Tomorrow!  Register Now 06/22/2021 07:00:00 AM
AMRN News: Amarin falls after Supreme Court rejection on Vascepa 06/21/2021 09:41:51 AM
PostSubject
#337034  Sticky Note BOARD WARNING - READ : IH Admin [Shelly] 04/25/21 04:13:46 PM
#318703  Sticky Note FINAL RESULTS rafunrafun 01/09/21 11:10:15 AM
#347988   P - 1) Amarin has not tweeted in rafunrafun 07/25/21 12:54:45 PM
#347987   Raf This is exactly what Amarin does. Pfizer tweet Pharmacydude 07/25/21 12:43:06 PM
#347986   ggwpq, is this the person you're referring to, lizzy241 07/25/21 11:26:34 AM
#347985   ggwpq, Thanks. Number sleven 07/25/21 10:42:45 AM
#347984   I believe EU SVP replacement had been selected ggwpq 07/25/21 10:35:58 AM
#347983   Rose ...here's the link to the original article Whalatane 07/25/21 10:12:49 AM
#347982   August is only a week away. We bidmark 07/25/21 09:47:43 AM
#347981   If Pfizer can tweet this: rafunrafun 07/25/21 09:25:14 AM
#347980   If AZN can tweet this: rafunrafun 07/25/21 09:13:21 AM
#347979   Thanks NS7, I had completely forgotten about finding rosemountbomber 07/25/21 08:28:04 AM
#347978   As long as he doesn't own a Filafel Nukemtiltheyglow 07/25/21 08:26:28 AM
#347977   Number sleven….you are probably correct. Allow me to The Irishman 07/25/21 08:10:25 AM
#347976   Rose, He becomes CEO August 1st. My guess Number sleven 07/25/21 07:16:31 AM
#347975   While this video relates to AMC and GME louieblouie 07/25/21 06:59:33 AM
#347974   When you say European setup, I hope you rosemountbomber 07/25/21 06:48:39 AM
#347973   Kiwi, I think your suggestion is a good rosemountbomber 07/25/21 06:39:20 AM
#347972   I gave the wrong link. Correct one here: rafunrafun 07/24/21 11:24:17 PM
#347971   Well they obviously need U to run their Whalatane 07/24/21 11:18:20 PM
#347970   Raf: No response necessary but I am extremely rafunrafun 07/24/21 10:31:33 PM
#347969   Statins take about 6 wks to have significant Whalatane 07/24/21 09:11:55 PM
#347968   Kiwi Yes I have seen it. Patients who were Pharmacydude 07/24/21 08:57:57 PM
#347967   Have you seen the latest data on Statins Whalatane 07/24/21 08:51:07 PM
#347966   gg PCSK 9’s. Repatha etc … Cut Whalatane 07/24/21 07:35:08 PM
#347965   Thx for those links Kiwi Whalatane 07/24/21 07:29:39 PM
#347964   gg. NVS is not buying any biotech Whalatane 07/24/21 07:28:42 PM
#347963   Irishman, I think as soon as KM is Number sleven 07/24/21 07:17:14 PM
#347962   I can’t disagree with you. However, I would The Irishman 07/24/21 07:08:05 PM
#347961   Pharmacydude… This is an excellent handout of data and The Irishman 07/24/21 07:01:27 PM
#347960   PD, impressive and thanks. Will definitely print it oneragman 07/24/21 06:22:53 PM
#347959   Thanks PD. That makes for a terrific rosemountbomber 07/24/21 05:48:53 PM
#347958   I just realize I have answered my own ggwpq 07/24/21 05:45:19 PM
#347957   One If you are seeing a new doc and Pharmacydude 07/24/21 05:43:06 PM
#347956   Sanofi vs Amarin rafunrafun 07/24/21 05:30:48 PM
#347955   From the JV SEC filing I read they sts66 07/24/21 05:30:29 PM
#347954   I don't understand why CV death made PCSK9's ggwpq 07/24/21 05:28:55 PM
#347953   Not sure how reliable that data is - sts66 07/24/21 05:24:40 PM
#347952   If that trial is a success we'll hear sts66 07/24/21 05:18:16 PM
#347951   Though REDUCE-IT only enrolled statin treated patients and ggwpq 07/24/21 05:16:21 PM
#347950   O - remember, there are multiple sets of rafunrafun 07/24/21 05:16:11 PM
#347949   Doubt it - IIRC a couple BPs released sts66 07/24/21 05:14:46 PM
#347948   seems to me all this would mostly go ranjo 07/24/21 05:09:53 PM
#347947   Pretty bold move by the CEO - but sts66 07/24/21 05:08:06 PM
#347946   raf, if Bhatt is making that statement, oneragman 07/24/21 05:06:47 PM
#347945   What's wacko is you needing to check this sts66 07/24/21 05:04:58 PM
#347944   Bodes well for PREP-IT: sts66 07/24/21 04:58:17 PM
#347943   Didn't Vascepa reduce CVD by 25% (ish) even rafunrafun 07/24/21 04:42:34 PM
#347942   NVS is positioning to push their upcoming PCSK9 ggwpq 07/24/21 04:33:43 PM
#347941   Sts, Thanks. Number sleven 07/24/21 04:28:52 PM
#347940   AMRN was worried enough about DS IPE that sts66 07/24/21 04:22:11 PM
#347939   DS cannot mention an Rx drug in their sts66 07/24/21 04:19:05 PM
PostSubject
Consent Preferences